Category Innovation/ R&D

Johnson & Johnson Denies Patent Pool Licences For HIV Medicines For The Poor

In a move public health advocates say is likely to bring negative consequences for low-income patients with HIV and AIDS, as well as negative publicity for the company, Johnson & Johnson recently announced that it would not enter into negotiations with the Medicines Patent Pool for voluntary licences that would allow several of key treatments to be made in more affordable generic form in developing countries.

Book: Shape Up International Reforms To Address Food Security

Current global institutional reforms of agricultural innovation systems and the commodification of crop diversity are not answering concerns regarding international equity in access to plant genetic resources, the handling of agricultural research, and the sharing of benefits arising from this research, according to a new book by Claudio Chiarolla, research fellow at the Paris-based Institut du développement durable et des relations internationales (IDDRI).

US Competitiveness Report Shows Struggle With Balance Of IP And Access

A new report from the United States Department of Commerce on competitiveness and innovation details the US need to boost innovation in order to compete globally and grow the economy. But while it stresses the need for strong intellectual property rights enforcement to create high-priced monopolies as an incentive for innovation, it also acknowledges that access to inexpensive technology and ideas is key to innovation and entrepreneurship. Furthermore, it shows that the rise in IP rights in recent years has been accompanied by a drop in innovation.

USPTO Issues Proposed Rules Implementing America Invents Act

The United States Patent and Trademark Office (USPTO) has published four notices of proposed rulemaking implementing provisions of the patent reform law signed last year. The issuance of the rules, which came ahead of schedule, opens a 60-day comment period on the draft rules.

Most-Read IP-Watch Posts Of 2011 Tell Story Of International IP Policymaking

The most-read Intellectual Property Watch stories of 2011 demonstrated the versatility and range of our readers from around the globe, from an intense focus on international and national copyright issues to bilateral and plurilateral free trade agreements, to issues in India and Brazil, patent laws, patents in agriculture, scientific knowledge, and of course, policies emerging in Geneva at the World Intellectual Property Organization, World Trade Organization, World Health Organization and elsewhere at the multilateral level. Most of all, they tell the story of the year gone by, with clear signals of what's to come in 2012.

EU Patent Advances: Parliament Could Vote In February, Court Location Still Up In Air

The European Parliament Legal Affairs Committee approval this week of a single patent for participating European Union members sets the stage for a February plenary vote in Parliament. But members’ inability to agree on where to locate the new unified patent litigation court means the Polish presidency won’t get to see finalisation of the process that will now head into 2012 under the guidance of Denmark.

A Call At OHCHR For Policy Action On Right To Enjoy Benefits Of Scientific Progress

The right of people to enjoy the benefits of scientific progress, the subject of an article in the International Covenant on Economic, Social and Cultural Rights, has received little attention and needs new attention in UN agencies, according to panellists yesterday at the Office of the United Nations High Commissioner for Human Rights (OHCHR). Human rights need to enter the arena in fora where scientific progress and its application are being discussed, they said in a public consultation on the ideas.

WIPO Patent Law Committee Sets Sights On “Balance” Among Member Interests

The World Intellectual Property Organization patent law committee this week is discussing a range of issues with a UN-style sensitivity to all levels of development and patent ownership. Issues on the agenda range from patent quality, public health, exceptions and limitations, client-attorney confidentiality, and technology transfer.